Calendar Genmab A/S

Equities

GMAB

DK0010272202

Market Closed - Nasdaq Copenhagen 11:59:32 2024-03-27 am EDT 5-day change 1st Jan Change
2,084 DKK -1.98% Intraday chart for Genmab A/S +3.73% -3.29%

Chart calendar Genmab A/S

fa3a4bab2298a82c29531.1MInjEgzTwFj1TdU27sjyLbobsv4a3_ZKfksFlO9Aqg.p6V17n53JWgBlEcDn8p3pYOBX4eBMk64GaZYUj37d56lkkjvF1gIZTaZDw~57ce80de300723d1e84a8c6dfb102ee6

Upcoming events on Genmab A/S

2024-05-02 11:00 am Q1 2024 Earnings Release
2024-08-01 11:00 am Q2 2024 Earnings Release
2024-11-06 11:00 am Q3 2024 Earnings Release
2025-02-18 Q4 2024 Earnings Release (Projected)
2025-05-06 Q1 2025 Earnings Release (Projected)
2025-08-05 Q2 2025 Earnings Release (Projected)
2025-11-04 Q3 2025 Earnings Release (Projected)

Past events on Genmab A/S

2024-03-13 09:00 am Annual General Meeting
2024-03-05 TD Cowen Health Care Conference
2024-02-27 UBS European Healthcare Conference
2024-02-14 12:00 pm Q4 2023 Earnings Call
2024-02-14 11:02 am Q4 2023 Earnings Release
2024-01-10 02:15 pm JPMorgan Healthcare Conference
2023-12-12 11:00 am R&D Day
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract Number 5089
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract Number 4757
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract Number 5158
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract Number 4481
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract Number 4457
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract Number 3135
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract Number 3092
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract Number 3053
2023-12-10 12:30 pm American Society of Hematology Meeting - Abstract Number 438
2023-12-09 08:30 pm American Society of Hematology Meeting - Abstract Number 1655
2023-12-09 08:30 pm American Society of Hematology Meeting - Abstract Number 1729
2023-12-09 08:30 pm American Society of Hematology Meeting - Abstract Number 1733
2023-12-09 08:30 pm American Society of Hematology Meeting - Abstract Number 1683

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million DKK
Released
Forecast
Spread
5 366
5 159
4.02%
10 111
9 843
2.72%
8 482
8 376
1.26%
14 595
14 068
3.75%
16 474
16 380
0.58%

19 619

EBITDA
Million DKK
Released
Forecast
Spread
2 777
2 460
12.89%
6 572
6 099
7.75%
3 266
3 111
4.98%
6 719
6 371
5.46%
5 616
5 721
-1.83%

6 567

EBIT
Million DKK
Released
Forecast
Spread
2 638
2 317
13.83%
6 313
5 967
5.79%
3 018
2 960
1.96%
6 357
6 008
5.81%
5 321
5 398
-1.42%

6 108

Earnings before Tax (EBT)
Million DKK
Released
Forecast
Spread
2 859
2 645
8.11%
5 904
5 723
3.17%
3 983
3 731
6.77%
7 035
8 905
-21%
5 637
6 236
-9.6%

6 659

Net income
Million DKK
Released
Forecast
Spread
2 166
2 085
3.89%
4 758
4 706
1.1%
3 008
2 847
5.64%
5 522
6 793
-18.71%
4 352
4 989
-12.77%

5 185

EPS
DKK
Released
Forecast
Spread
34,0
32,8
3.61%
72,2
69,4
4.06%
45,5
43,8
3.94%
83,7
104
-19.22%
66,0
76,2
-13.35%

79,9

Announcement Date19/02/2023/02/2116/02/2222/02/2314/02/24-

Quarterly results

Fiscal PeriodDecember 2020 S1 2021 S1 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2025 Q1
Net sales
Million DKK
Released
Forecast
Spread
6 343
6 164
2.9%
3 553
3 224
10.2%
2 619
2 538
3.19%
2 119
2 074
2.15%
3 162
2 833
11.6%
5 281
5 136
2.82%
4 087
3 634
12.46%
5 227
4 727
10.57%
2 854
2 809
1.62%
4 198
4 070
3.13%
7 052
6 896
2.26%
4 744
4 474
6.03%
4 678
4 610
1.48%

3 997


4 969


9 117


5 236


5 436


4 706

EBITDA
Million DKK
Released
Forecast
Spread
4 583
4 480
2.3%
1 345
980
37.24%
1 016
776
30.87%
529
358
47.73%
1 263
1 312
-3.74%
1 792
1 951
-8.15%
1 953
1 583
23.36%
2 974
2 708
9.84%
458
583
-21.48%
1 520
1 670
-8.96%
1 978
2 145
-7.79%
1 739
1 646
5.65%
1 899
1 804
5.28%

855


1 853


2 815


1 863


1 682


822

EBIT
Million DKK
Released
Forecast
Spread
4 568
4 389
4.08%
1 319
864
52.66%
809
772
4.76%
514
442
16.3%
1 247
1 156
7.87%
1 761
1 814
-2.92%
1 931
1 541
25.34%
2 665
2 314
15.17%
437
527
-17.08%
1 497
1 573
-4.85%
1 934
1 977
-2.18%
1 717
1 702
0.87%
1 670
1 772
-5.73%

796


1 688


2 630


1 742


1 789


767

Earnings before Tax (EBT)
Million DKK
Released
Forecast
Spread
4 682
4 682
0%
1 846
1 759
4.95%
966
772
25.06%
612
499
22.59%
2 489
1 183
110.39%
3 101
1 932
60.51%
3 272
1 584
106.63%
662
2 199
-69.9%
286
402
-28.85%
1 723
1 602
7.57%
2 009
1 927
4.26%
2 702
1 774
52.33%
926
1 888
-50.95%

927


1 900


2 876


1 943


1 928


583

Net income
Million DKK
Released
Forecast
Spread
3 647
4 573
-20.25%
1 402
1 372
2.19%
716
603
18.69%
465
357
30.19%
1 891
913
107.1%
2 356
1 469
60.38%
2 582
1 187
117.46%
584
1 556
-62.47%
226
397
-43.08%
1 357
1 204
12.72%
1 583
1 503
5.32%
2 129
1 382
54.01%
640
1 439
-55.52%

771


1 416


2 215


1 474


1 503


455

EPS
DKK
Released
Forecast
Spread
55,5
70,2
-20.91%
21,3
20,9
1.67%
10,8
9,25
16.99%
7,05
5,39
30.88%
28,7
13,8
106.99%
35,7
22,1
61.58%
39,2
18,3
113.88%
8,82
23,2
-61.91%
3,43
5,07
-32.28%
20,6
19,3
7.03%
24,0
22,7
5.86%
32,3
21,2
52.42%
9,67
23,0
-57.93%

11,2


22,7


34,2


23,3


23,0


19,1

Announcement Date12/08/2011/08/2116/02/2211/05/2210/08/2210/08/2209/11/2222/02/2310/05/2303/08/2303/08/2307/11/2314/02/24------

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise